The Drug Enforcement Agency (DEA) recently proposed new rule changes for telemedicine prescribing of controlled substances. This rule is more restrictive than the current Covid-19
The U.S. Department of Health and Human Services (HHS) recently announced that they are extending the flexibilities related to Medicare telemedicine services due to the
Healthcare is a highly regulated industry, and ensuring compliance with regulations and laws is essential for any Health IT company. One of the most critical
Congress Eliminates the NADEAN Requirement With the Consolidated Appropriations Act of 2023, Congress eliminated the Drug Addiction Treatment Act (DATA) Waiver Program. This program required
Drummond experts can help you prepare The Drug Enforcement Administration (DEA) has announced the electronic prescribing of controlled substances (EPCS) Interim Final Rule will be
EPCS Clients: We’ve Got Your Back!
Will DEA Make Changes to its Final Rule? In June 2020, a decade after publishing the interim final rule (IFR) for controlled substance e-prescribing, the Drug Enforcement
HHS Changes Guidelines for Buprenorphine Administration As of January 2021, the U.S. Department of Health and Human Services (HHS) changed the practice guidelines for the
Discover the keys to a successful EPCS audit with our DEA approved certification process. Find out why Drummond is a leading DEA EPCS auditor today
For a PDF Download CLICK HERE Drummond Extends Relationship with IntrinsiQ Specialty Solutions as a Compliance Partner and More Challenge IntrinsiQ Specialty Solutions (IQSS), a
© 2023 Drummond Group. All rights reserved.
Please fill out the form below to download the guide.
Please fill out the form below to download the guide.
Please fill out the form below to download the guide.
